Ausgabe 2/2015
Inhalt (8 Artikel)
Role of Apomorphine in the Treatment of Parkinson’s Disease
Allison Boyle, William Ondo
mTOR Inhibition in Epilepsy: Rationale and Clinical Perspectives
Adam P. Ostendorf, Michael Wong
Seizure Associated with Clozapine: Incidence, Etiology, and Management
Andrew M. Williams, Susie H. Park
Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms
Laure Rouch, Philippe Cestac, Olivier Hanon, Charlène Cool, Catherine Helmer, Béatrice Bouhanick, Bernard Chamontin, Jean-Franҫois Dartigues, Bruno Vellas, Sandrine Andrieu
The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research
Nicola C. Savill, Jan K. Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer, Himanshu P. Upadhyaya, David Coghill
Taming Glutamate Excitotoxicity: Strategic Pathway Modulation for Neuroprotection
Ming Jia, Steve A. Noutong Njapo, Vaibhav Rastogi, Vishnumurthy Shushrutha Hedna
Weight Regain after Discontinuation of Topiramate Treatment in Patients with Migraine: a Prospective Observational Study
Alberto Verrotti, Pasquale Parisi, Sergio Agostinelli, Giulia Loiacono, Francesca Marra, Giangennaro Coppola, Laura Rosa Pisani, Gaetano Gorgone, Pasquale Striano, Francesco Pisani, Vincenzo Belcastro
Peginterferon Beta-1a: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
Sheridan M. Hoy